| CBIO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CBIO shares outstanding history going back to 2/13/2017:
Also see: CBIO Market Cap History CBIO YTD Return |
CBIO Shares Outstanding History — Catalyst Biosciences Share Count Over Time
As of 4/24/2026 Catalyst Biosciences has 27.57 million CBIO shares outstanding. Investors often track the CBIO shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CBIO share count trends over time, with 35 historical shares outstanding datapoints presented, dating back to 2/13/2017.
| CBIO Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CBIO Historical Shares Outstanding: +140.37% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CBIO Stock Price Chart |
| About Crescent Biopharma Inc (New) |
| GlycoMimetics, Inc. is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers, including acute myeloid leukemia (AML) and for inflammatory diseases. It is developing a pipeline of glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in biological processes, to inhibit disease-related functions of carbohydrates, such as the roles they play in inflammation, cancer and infection. Its drug candidates include Uproleselan, GMI-1687, Galectin Antagonists and GMI-1359. We show 35 historical shares outstanding datapoints in our coverage of CBIO's shares outstanding history. Understanding the changing numbers of CBIO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CBIO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CBIO by allowing them to research CBIO shares outstanding history as well as any other stock in our coverage universe. |
| CBIO Current Stock Quote |
Quotes delayed 20 minutes  Free CBIO Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CBIO Share Performance |
| Shares Outstanding Peers |
| Catalyst Biosciences (CBIO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CBLI Shares Outstanding History CBM Shares Outstanding History CBMG Shares Outstanding History CBPO Shares Outstanding History CBUS Shares Outstanding History CCCC Shares Outstanding History CCEL Shares Outstanding History CCRN Shares Outstanding History CCXI Shares Outstanding History CDAK Shares Outstanding History More Healthcare companies » |
CBIO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
